Skip to main content
. 2016 Jul 27;6:30377. doi: 10.1038/srep30377

Figure 4. Effect of RNaseH1 knockdown on other hepatotoxic gapmers.

Figure 4

Mice that had received siRNA–invivofectamine complex were administrated hepatotoxic gapmers targeting ApoB (20 mg/kg), Hprt1 (80 mg/kg), or human Kif11 (80 mg/kg). Upper panels show plasma ALT; lower panels show plasma AST. ApoB (a,d), Hprt1 (b,e), and human Kif11 (c,f). (n = 3, mean ± S.D.) #Mouse was euthanized because of acute weight loss.